EQA 2024 - Point Of Care testing (BD) |
---|
Expert Biologists - Scheme Coordinators:
Chantal BON, Marie LOPEZ and Bernard POGGI EQA performed since 2018
Number of participating laboratories in 2023: 230 |
Scheme organized by ProBioQual and placed under the aegis of the FAEEQ |
1 – Scheme overview
This external quality assessment allows you to check the accuracy of the results rendered by your point of care testing according to the standard NF EN ISO 22870 . As the samples are ready for use, they can be analyzed directly by healthcare staff as a real patient sample.
2 possible cumulative options (each option is sold separately):
For the 2 options, one registration allows acces to 6 entries of results per analyte.
Program limited to France excluding Corsica. |
2 – Assessment frequency
Biochemistry / Hematology (BDB) option:
Hemostasis Option (BDH):
3 – List of analytes assessed
Biochemistry / Hematology (BDB) option:
Hemostasis Option (BDH):
4 – Description of the control samples
Biochemistry / Hematology (BDB) option:
Liquid human blood (1.2 mL samples, ready to use). Sampling carried out on the day of dispatch after consent, delivered within 24 hours and to be assayed on the day of receipt.
Hemostasis Option (BDH):
Liquid human plasma (0.3 mL samples, ready to use)
Hemostasis Option (BDH): The samples are compatible with iSTAT by ABBOTT, Xprecia Stride by SIEMENS and CoaguCheck by ROCHE. If you are using other analyzers: contact us. |
| Confidentiality Policy | General Terms of Sale | | Last updated : 04/09/2023 | Copyright © 2011-2023 ProBioQual All rights reserved. |